Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention

被引:286
|
作者
Hayes, JD [1 ]
McMahon, M [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland
关键词
chemoprevention; detoxication; antioxidant responsive element; Nrf1; Nrf2; cytochrome P450; glutathione S-transferase; mitogen activated protein kinase; carcinogenesis; protein kinase C;
D O I
10.1016/S0304-3835(01)00695-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article provides an overview of the mechanisms by which cancer chemopreventive blocking agents increase the expression of detoxication and antioxidant genes. These agents all appear capable of transcriptionally activating a gene battery that includes NAD(P)H:quinone oxidoreductase, aldo-keto reductases, glutathione S-transferases, gamma -glutamylcysteine synthetase, glutathione synthetase and heme oxygenase. Gene induction occurs through the antioxidant responsive element (ARE), a process that is dependent on the Nuclear Factor-Erythroid 2p45-related factors, Nrf1 and Nrf2. Under basal conditions, these basic region leucine zipper (bZIP) transcription factors are located in the cytoplasm of the cell bound to Keap1, and upon challenge with inducing agents, they are released from Keap1 and translocate, to the nucleus. Within the nucleus, Nrf1 and Nrf2 are recruited to the ARE as heterodimers with either small Maf proteins, FosB, c-Jun, JunD, activating transcription factor 2 (ATF2) or ATF4. The role of protein kinases in transducing chemical stress signals to the bZIP factors that affect gene induction through the ARE is discussed. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:103 / 113
页数:11
相关论文
共 50 条
  • [41] Molecular basis of cancer
    Meza-Junco, Judith
    Montano-Loza, Aldo
    Aguayo-Gonzalez, Alvaro
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2006, 58 (01): : 56 - 70
  • [42] Genetic predisposition as a basis for chemoprevention, surgical and other interventions in colorectal cancer
    Müller, H
    Plasilova, M
    Russell, AM
    Heinimann, K
    TUMOR PREVENTION AND GENETICS, 2003, 163 : 235 - 247
  • [43] Cancer Chemoprevention and Piperine: Molecular Mechanisms and Therapeutic Opportunities
    Rather, Rafiq A.
    Bhagat, Madhulika
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2018, 6
  • [44] Soy Phytoestrogens and Breast Cancer Chemoprevention: Molecular Mechanisms
    Satih, Samir
    Rabiau, Nadege
    Bignon, Yves-Jean
    Bernard-Gallon, Dominique J.
    CURRENT NUTRITION & FOOD SCIENCE, 2008, 4 (04) : 259 - 264
  • [45] Mangiferin in cancer chemoprevention and treatment: pharmacokinetics and molecular targets
    Rajendran, Peramaiyan
    Rengarajan, Thamaraiselvan
    Nandakumar, Natarajan
    Divya, H.
    Nishigaki, Ikuo
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2015, 35 (01) : 76 - 84
  • [46] MOLECULAR-BASIS OF ENDOCRINE-RESPONSIVE CANCERS
    WITTLIFF, JL
    CLINICAL PHYSIOLOGY AND BIOCHEMISTRY, 1987, 5 (3-4) : 160 - 178
  • [47] Cell cycle control as a basis for cancer chemoprevention through dietary agents
    Meeran, Syed Musthapa
    Katiyar, Santosh Kumar
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 2191 - 2202
  • [48] Molecular epidemiology and retinoid chemoprevention of head and neck cancer
    Khuri, FR
    Lippman, SM
    Spitz, MR
    Lotan, R
    Hong, WK
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (03): : 199 - 211
  • [49] Drug Development for Cancer Chemoprevention: Focus on Molecular Targets
    Johnson, Karen A.
    Brown, Powel H.
    SEMINARS IN ONCOLOGY, 2010, 37 (04) : 345 - 358
  • [50] Molecular basis of heme oxygenase-1 induction: Implications for chemoprevention and chemoprotection
    Prawan, A
    Kundu, JK
    Surh, YJ
    ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (11-12) : 1688 - 1703